Insulet financials
$132.84−0.20%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $801.7M | $761.7M | $783.8M | $706.3M | $649.1M | $569.0M | $597.5M | $543.9M | $488.5M | $441.7M | $509.8M | $432.7M |
| Gross profit | $562.6M | $529.0M | $568.6M | $510.1M | $452.2M | $409.1M | $430.9M | $377.1M | $330.9M | $306.8M | $361.2M | $293.3M |
| Gross margin | 70.2% | 69.4% | 72.5% | 72.2% | 69.7% | 71.9% | 72.1% | 69.3% | 67.7% | 69.5% | 70.9% | 67.8% |
| Operating income | $129.7M | $122.1M | $146.3M | $117.7M | $121.1M | $88.8M | $109.3M | $88.1M | $54.5M | $56.9M | $106.4M | $54.8M |
| Net income | $95.0M | $91.1M | $101.6M | $87.6M | $22.5M | $35.4M | $100.7M | $77.5M | $188.6M | $51.5M | $103.3M | $51.9M |
| Net margin | 11.8% | 12.0% | 13.0% | 12.4% | 3.5% | 6.2% | 16.9% | 14.2% | 38.6% | 11.7% | 20.3% | 12.0% |
| Diluted EPS | $1.37 | $1.30 | $1.41 | $1.24 | $0.32 | $0.50 | $1.36 | $1.08 | $2.59 | $0.73 | $1.28 | $0.74 |
| EBITDA | $156.4M | $148.3M | $170.7M | $139.7M | $143.4M | $110.5M | $130.8M | $109.4M | $73.7M | $75.7M | $106.4M | $73.5M |
| Operating cash flow | $88.4M | $113.8M | $183.3M | $125.7M | $196.4M | $63.9M | $147.7M | $108.3M | $86.8M | $87.6M | $45.2M | $56.0M |
| Free cash flow | $55.9M | $89.5M | $42.4M | $94.7M | $177.8M | $51.6M | $91.7M | $79.2M | $61.9M | $63.6M | $13.6M | $33.6M |
| Diluted shares | 69.4M | 70.2M | 72.1M | 70.7M | 70.7M | 74.1M | 74.1M | 74.0M | 73.8M | 73.7M | 80.7M | 73.6M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $534.9M | $480.4M | $716.1M | $757.4M | $1.12B | $1.28B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $948.4M | $948.1M | $949.2M | $1.01B | $1.40B | $1.70B |
| Total assets | $3.17B | $2.99B | $3.19B | $3.03B | $3.47B | $3.52B |
| Total liabilities | $1.74B | $1.68B | $1.68B | $1.65B | $2.01B | $2.19B |
| Shareholders' equity | $1.42B | $1.30B | $1.52B | $1.38B | $1.46B | $1.33B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology